SARA TORGERSON: Open Payments
NPI 1962182386 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 46 payments from 7 companies in 2025. Trend: 2023 $272 · 2024 $133 · 2025 $898
Food & beverage: $798Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $270 |
| Madrigal Pharmaceuticals | 11 | $234 |
| ABBVIE INC. | 12 | $182 |
| CORDIS US CORP. | 3 | $81 |
| Lilly USA, LLC | 3 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| PFIZER INC. | 1 | $17 |
Products named: TREMFYA, REZDIFFRA, MYNX CONTROL VENOUS, MAVYRET, LINZESS, OMVOH, ZENPEP, VELSIPITY.
Industry payments across NV — which companies pay providers there.
